“ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients”, Clinics, vol. 73, p. e1err, Jan. 2018, doi: 10.6061/clinics/2018/e1err.